Large cell/anaplastic medulloblastomas and medullomyoblastomas: Clinicopathological and genetic features

Journal of Neurosurgery

Volumn 95, Issue 1, 2001, Pages 82-88

  Leonard, J R ^a   Cai, D X ^a   Rivet, D J ^a   Kaufman, B A ^a   Park, T S ^a   Levy, B K ^a   Perry, A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aneuploidy; C myc; Fluorescence in situ hybridization; Medulloblastoma

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; ANEUPLOIDY; ARTICLE; CANCER STAGING; CEREBROSPINAL FLUID; CHILD; CHROMOSOME 17Q; CHROMOSOME 22Q; CHROMOSOME DELETION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GRANULAR CELL TUMOR; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOCHROMOSOME; LARGE CELL CARCINOMA; LYMPH NODE METASTASIS; MEDULLOBLASTOMA; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0034865073     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.95.1.0082     Document Type: Article

References (30)

1. Prognostic implications of chromosome 17p deletions in human medulloblastomas
2. Histopathology and prognosis of Wilms tumor. Results from the first National Wilms' Tumor Study
3. Narrowing the critical region for a rhabdoid tumor locus in 22q11
4. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors
5. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system
6. Malignant rhabdoid tumor of the central nervous system
7. "Large cell/anaplastic" medulloblastomas - A pediatric oncology group study
8. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors
9. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A Pediatric Oncology Group study
10. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis
11. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone
12. Medulloblastoma
13. Medulloblastoma with extensive nodularity: A variant with favorable prognosis
14. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior
15. Isochromosome 17q is a constant finding in medulloblastoma. An interphase cytogenetic study on tissue sections
16. Oncogene amplification in medulloblastoma: Analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization
17. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors
18. Atypical teratoid tumor of infancy: Definition of an entity
19. Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas
20. Survivors of medulloblastoma: Implications for program planning
21. Comparative genomic hybridization and histological variation in primitive neuroectodermal tumors
22. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy
23. Combined treatment modality for medulloblastoma in childhood: Effects on neuropsychological functioning
24. Medulloblastoma: A population-based study of 532 cases
25. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity
26. hSNF5/INII inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors
27. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome
28. Deletion mapping on chromosome 17p in medulloblastoma
29. Prognostic factors in medulloblastoma, including DNA ploidy